Evolent Health, Inc (EVH): Price and Financial Metrics

Evolent Health, Inc (EVH): $34.07

4.30 (+14.44%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

Add EVH to Watchlist
Sign Up

Industry: Medical - Services

Industry

C

Ranked

#63 of 69

in industry

EVH Price/Volume Stats

Current price $34.07 52-week high $36.70
Prev. close $29.77 52-week low $23.33
Day low $31.30 Volume 3,795,400
Day high $34.07 Avg. volume 1,072,451
50-day MA $31.08 Dividend yield N/A
200-day MA $29.17 Market Cap 3.92B

EVH Stock Price Chart Interactive Chart >

EVH POWR Grades

  • EVH scores best on the Growth dimension, with a Growth rank ahead of 98.33% of US stocks.
  • The strongest trend for EVH is in Quality, which has been heading up over the past 26 weeks.
  • EVH's current lowest rank is in the Sentiment metric (where it is better than 9.53% of US stocks).

EVH Stock Summary

  • The price/operating cash flow metric for EVOLENT HEALTH INC is higher than 91.12% of stocks in our set with a positive cash flow.
  • In terms of twelve month growth in earnings before interest and taxes, EVOLENT HEALTH INC is reporting a growth rate of 189.66%; that's higher than 93.79% of US stocks.
  • Revenue growth over the past 12 months for EVOLENT HEALTH INC comes in at 46.99%, a number that bests 90.49% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to EVH, based on their financial statements, market capitalization, and price volatility, are DNUT, MEI, RMAX, BRP, and ALIT.
  • Visit EVH's SEC page to see the company's official filings. To visit the company's web site, go to www.evolenthealth.com.

EVH Valuation Summary

  • In comparison to the median Healthcare stock, EVH's price/sales ratio is 4.55% lower, now standing at 2.1.
  • EVH's price/earnings ratio has moved down 0 over the prior 104 months.

Below are key valuation metrics over time for EVH.

Stock Date P/S P/B P/E EV/EBIT
EVH 2023-12-29 2.1 3.5 -33.8 -34.4
EVH 2023-12-28 2.2 3.5 -34.3 -34.8
EVH 2023-12-27 2.1 3.5 -34.0 -34.5
EVH 2023-12-26 2.1 3.5 -33.8 -34.4
EVH 2023-12-22 2.1 3.4 -32.9 -33.5
EVH 2023-12-21 2.0 3.3 -32.4 -33.1

EVH Growth Metrics

    The 5 year cash and equivalents growth rate now stands at -34.85%.
  • Its 5 year revenue growth rate is now at 188.1%.
  • The 5 year price growth rate now stands at -63.43%.
EVH's revenue has moved up $244,295,000 over the prior 15 months.

The table below shows EVH's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 1,217.939 19.408 -13.462
2022-06-30 1,087.825 67.379 -28.625
2022-03-31 989.943 29.468 -33.144
2021-12-31 907.957 38.747 -37.601
2021-09-30 931.522 -40.76 -46.579
2021-06-30 973.644 -105.76 -70.887

EVH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • EVH has a Quality Grade of D, ranking ahead of 14.15% of graded US stocks.
  • EVH's asset turnover comes in at 0.713 -- ranking 221st of 563 Business Services stocks.
  • EVOL, GLOB, and AKAM are the stocks whose asset turnover ratios are most correlated with EVH.

The table below shows EVH's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.713 0.254 -0.052
2021-06-30 0.726 0.244 -0.113
2021-03-31 0.742 0.245 -0.547
2020-12-31 0.746 0.228 -0.601
2020-09-30 0.704 0.220 -0.869
2020-06-30 0.636 0.223 -0.795

EVH Price Target

For more insight on analysts targets of EVH, see our EVH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $28.33 Average Broker Recommendation 1.43 (Moderate Buy)

Evolent Health, Inc (EVH) Company Bio


Evolent Health provides health-care delivery and payment solutions in the United States. The company was founded in 2011 and is based in Arlington, Virginia.


EVH Latest News Stream


Event/Time News Detail
Loading, please wait...

EVH Latest Social Stream


Loading social stream, please wait...

View Full EVH Social Stream

Latest EVH News From Around the Web

Below are the latest news stories about EVOLENT HEALTH INC that investors may wish to consider to help them evaluate EVH as an investment opportunity.

Investors Will Want Evolent Health's (NYSE:EVH) Growth In ROCE To Persist

There are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...

Yahoo | December 11, 2023

How Much Upside is Left in Evolent Health (EVH)? Wall Street Analysts Think 59.66%

The consensus price target hints at a 59.7% upside potential for Evolent Health (EVH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Yahoo | December 7, 2023

Insider Sell: CEO Seth Blackley Sells 141,000 Shares of Evolent Health Inc (EVH)

In a notable insider transaction, CEO Seth Blackley has sold 141,000 shares of Evolent Health Inc (NYSE:EVH) on December 5, 2023.

Yahoo | December 7, 2023

Evolent Health Looks to Start an Advance, But When?

Evolent Health, Inc. was rated a new market outperform (buy) at JMP Securities with a $37 price target. Evolent provides "an integrated administrative and clinical platform for health plan administration and population health management". In this daily bar chart of EVH, below, I can see that prices have made a choppy decline since April.

Yahoo | December 6, 2023

Evolent Health, Inc. Announces Pricing of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan

Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable ("Evolent"), today announced the pricing of $350.0 million aggregate principal amount of 3.50% convertible senior notes due 2029. The notes are being offered only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the

Yahoo | December 6, 2023

Read More 'EVH' Stories Here

EVH Price Returns

1-mo 12.59%
3-mo 15.26%
6-mo 32.47%
1-year -2.41%
3-year 73.56%
5-year 132.24%
YTD 3.15%
2023 17.63%
2022 1.48%
2021 72.61%
2020 77.13%
2019 -54.64%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!